i
Important informations
Instagram
Portal
Donate now

Our researchers

Aucun résultat

Dr. Vicky Tagalakis

Vicky Tagalakis, MD, MSc, FRCPC

Clinical Epidemiology

Deep vein thrombosis, Pharmacoepidemiology, Population studies, Pulmonary embolism, Venous thrombosis
  • Senior Investigator, Lady Davis Institute for Medical Research
  • Physician-in-Chief, Jewish General Hospital, CIUSSS West-Central Montreal
  • Associate Chair, Department of Medicine, McGill University
  • Associate Member, Department of Epidemiology, Biostatistics and Occupational Health, McGill University

Contact details

(514) 340-8222 ext. 24665
vicky.tagalakis@mcgill.ca
@Vtagalakis

Assistant contact details

  • Carole Bohbot,
    (514) 340-8222 ext. 24562
    carole.bohbot@ladydavis.ca

Snapshot

Dr. Vicky Tagalakis’ research program theme is in venous thromboembolism (VTE) with a focus in population level epidemiologic studies to address prognosis, etiologic risk factors and management of thrombotic disorders, with an added focus on cancer related thrombotic disorders. Her program focuses on leveraging large scale healthcare administrative databases to conduct population-based studies on quality of care and effectiveness related to the management of VTE and is based on the use of pharmacoepidemiology methodology to address effects.

Important Links :

See Dr. Vicky Tagalakis' publications on PubMed

Major Research Activities

Dr. Vicky Tagalakis’ research program theme is in venous thromboembolism (VTE) with a focus in population level epidemiologic studies to address prognosis, etiologic risk factors and management of thrombotic disorders, with an added focus on cancer related thrombotic disorders. Her program focuses on leveraging large scale healthcare administrative databases to conduct population-based studies on quality of care and effectiveness related to the management of VTE and is based on the use of pharmacoepidemiology methodology to address effects. Some key focus areas include:

  • Management of thrombotic disorders in patients with cancer;
  • Use of anticoagulants in women with thrombosis;
  • Use of anticoagulants in patients with advanced renal disease.

Recent Publications and References